What Probiotics Have Lactobacillus and Bifidobacterium?

Discover the functional synergy between the two most beneficial bacterial groups and the definitive strategy for effective sourcing.

Most broad-spectrum probiotic supplements contain strains from both Lactobacillus and Bifidobacterium, and many fermented foods naturally harbor one or both genera. These two groups of bacteria are the workhorses of the probiotic world, but knowing they appear on a label does not tell you much by itself. The species within each genus, the actual viability of those organisms when you swallow them, and whether your supplement’s label is even accurate are all questions worth digging into.

The Name Shuffle You Should Know About

If you have been buying probiotics for years, you may have noticed some labels now list unfamiliar names where “Lactobacillus” used to be. In 2020, taxonomists formally split the old Lactobacillus genus into 25 separate genera based on genomic analysis, creating names like Lacticaseibacillus, Lactiplantibacillus, Limosilactobacillus, and others. The research behind this reclassification showed that the old Lactobacillus group was genetically sprawling, with some species more distantly related to each other than humans are to fish.

What this means for you as a consumer is that the popular strain Lactobacillus rhamnosus is now technically Lacticaseibacillus rhamnosus, and Lactobacillus plantarum is now Lactiplantibacillus plantarum. Some supplement manufacturers have updated their labels; many have not. Both the old and new names refer to the same organisms. Bifidobacterium, by contrast, has kept its name intact. So when you see “Lactobacillus” on a product, it is either using the legacy naming or it contains one of the species that stayed in the slimmed-down Lactobacillus genus, like L. acidophilus or L. delbrueckii. Either way, the bacteria inside are the same ones researchers have studied for decades.

Fermented Foods That Naturally Contain Both

Yogurt is the first thing most people think of, and it does contain Lactobacillus species, particularly L. delbrueckii subsp. bulgaricus, which is one of the standard starter cultures. Bifidobacterium species show up in yogurt too, though they tend to be present at lower levels and are sometimes added separately by manufacturers rather than occurring naturally in the fermentation. Species like B. animalis, B. longum, B. bifidum, and B. breve have been found in yogurt, kefir, traditional Mongolian fermented mare’s milk, and raw milk cheeses, though often as transient or low-abundance members of the microbial community.

Getting bifidobacteria to thrive in dairy products is harder than it sounds. Their survival depends on the specific strain used, how it interacts with the lactic acid bacteria already in the product, the fermentation conditions, and storage temperature. This is why many commercial yogurts that prominently feature Bifidobacterium on the label add those strains after fermentation rather than relying on the fermentation process to cultivate them.

Beyond dairy, fermented vegetables like kimchi and sauerkraut are rich in Lactobacillus-family organisms. Kimchi, for instance, has yielded isolates of L. rhamnosus, L. sakei, and Lactiplantibacillus plantarum. Bifidobacterium, however, is less commonly found in vegetable ferments. If your goal is to consume both genera through food alone, fermented dairy is a more reliable bet than fermented vegetables, though supplements remain the most controlled option.

Multi-Strain Supplements

The supplement market is packed with products combining Lactobacillus and Bifidobacterium strains. One well-known example is the eight-strain blend formerly sold as VSL#3 (now marketed under different names due to trademark disputes). That formulation includes Lactobacillus plantarum, L. acidophilus, L. casei, L. delbrueckii subsp. bulgaricus, Bifidobacterium breve, B. infantis, and B. longum, along with Streptococcus thermophilus. This kind of multi-strain approach is common across the industry, though the specific species and strains vary widely from product to product.

When shopping for a supplement, the strain designation matters more than the genus. Two products can both list “Lactobacillus acidophilus” and contain entirely different strains with different clinical evidence behind them. The strain is identified by a code after the species name, like L. acidophilus La-5 or B. animalis Bb-12. Products that list only the genus and species without identifying the strain are giving you incomplete information.

Why These Two Genera Work Well Together

Lactobacillus and Bifidobacterium are not just thrown together in supplements because they are both “good bacteria.” They occupy different metabolic niches and can feed each other through a process called cross-feeding. When a Lactobacillus strain breaks down a prebiotic fiber like inulin, it produces lactate and releases simple sugars. A Bifidobacterium strain in the same environment can use the acetate it produces alongside that lactate to fuel butyrate-producing bacteria, which are critical for colon health. In lab experiments, co-cultures of Bifidobacterium adolescentis with butyrate-producing gut bacteria showed that neither could produce butyrate alone on starch, but together they created a metabolic chain that resulted in significant butyrate output.

This metabolic teamwork extends to prebiotics. A study of fermented milk made with L. acidophilus La-5 and B. animalis Bb-12 found that adding inulin of any chain length boosted the viability of both strains. This is why many supplements bundle a prebiotic fiber alongside both genera and call the product a “synbiotic.” The prebiotic feeds the probiotics, and the probiotics feed each other and the wider gut ecosystem.

How They Protect You

Both genera defend the gut through overlapping but distinct mechanisms. Lactobacillus-family species compete with harmful bacteria for space on the intestinal lining, produce lactic acid that lowers local pH, and secrete antimicrobial peptides called bacteriocins that can kill pathogens like Listeria, Clostridium, and Salmonella. Bifidobacterium species similarly suppress pathogens by producing acetate and strengthening the mucosal immune response.

Both genera also help maintain the physical barrier of the gut lining. Specific strains of Lactobacillus and Bifidobacterium have been shown to increase the production of tight junction proteins that hold intestinal cells together, reduce inflammatory signaling, and keep the gut wall from becoming excessively permeable. These effects are highly strain-specific, meaning one Lactobacillus strain might strengthen the barrier while a closely related strain does nothing measurable. This strain-level specificity is the reason researchers keep emphasizing that “probiotics” is not a useful catch-all term for predicting what a particular product will do.

Immune Effects Differ Between the Two

Bifidobacterium has been especially well-studied for its immune-modulating properties. It promotes the expansion of regulatory T cells, which are the immune system’s peacekeepers, dampening overactive inflammatory responses. It also modulates the behavior of dendritic cells and macrophages and tones down intestinal immune programs that drive allergic and autoimmune reactions.

Lactobacillus species share some of these immune effects but have been studied in somewhat different clinical contexts. In one trial, L. plantarum IS-10506 given to HIV-infected children receiving antiretroviral therapy led to a significant increase in a marker of regulatory T cell activity compared to placebo. That does not mean Lactobacillus strains are “better” for immunity; it means the two genera often get tested in different patient populations for different conditions. The clinical picture is fragmented, and generalizing from one strain to an entire genus remains risky.

Bifidobacterium’s Special Role in Infants

Bifidobacterium dominates the gut of healthy breastfed infants, and this is not accidental. Human breast milk contains complex sugars called human milk oligosaccharides (HMOs) that the infant cannot digest but that certain Bifidobacterium species, especially B. longum subsp. infantis, thrive on. B. infantis can metabolize the most abundant HMOs, including fucosylated and sialylated forms, acting as a bridge between mother’s milk and the infant’s developing immune system. As an infant starts eating solid food, the Bifidobacterium population gradually declines and bacteria that break down plant fibers take over.

This is why infant-specific probiotic formulations lean heavily on Bifidobacterium and particularly on B. infantis. Lactobacillus species are present in the infant gut too, but they are not the dominant players in the way Bifidobacterium is during breastfeeding. For adults, by contrast, the balance shifts, and Lactobacillus-family species become more relevant to the small intestine and other body sites.

Lactobacillus Beyond the Gut

Lactobacillus species play a major protective role in the vaginal microbiome, a context where Bifidobacterium is largely absent. A healthy vaginal microbiota is dominated by Lactobacillus species, which maintain an acidic pH and produce antimicrobial compounds that guard against bacterial and fungal infections. Research has found that lactic acid at vaginal pH is a potent antimicrobial agent, and its protective effect is far stronger than previously estimated, suggesting that when lactobacilli dominate, women have substantially more lactic-acid-mediated defense than older models predicted. This is why vaginal probiotic products focus exclusively on Lactobacillus strains rather than Bifidobacterium.

Label Accuracy Problems

Buying a product that lists Lactobacillus and Bifidobacterium on the label does not guarantee you are getting what is advertised. Independent testing has found significant discrepancies. In one analysis, roughly half of the commercial probiotic products tested had counts lower than their labels claimed, with the worst offenders, two chocolate-bar probiotics, falling more than 30 times below their stated counts. DNA analysis confirmed that most labeled species were present, but products containing more than three strains frequently showed discrepancies. Many products also used outdated strain names that no longer match current taxonomy.

A separate study using advanced DNA sequencing found that about half of the probiotic products examined had at least one labeled strain that could not be detected at all. Some labeling errors are more alarming than others. An audit of supplements in Ghana found products claiming to contain “Lactobacillus spores,” which is biologically impossible since Lactobacillus species do not form spores. The likely explanation was that the manufacturer confused Lactobacillus with the spore-forming genus Bacillus.

Third-party testing organizations like USP, NSF, and ConsumerLab offer verified seals that indicate a product has been independently tested for identity and potency. If label accuracy matters to you, and it should, look for one of these marks.

Surviving the Trip to Your Gut

Both Lactobacillus and Bifidobacterium face the same fundamental challenge: stomach acid and bile salts can kill them before they reach the intestine where they do their work. Both genera have evolved molecular tools to handle bile, including proteins that pump bile salts out of the cell and enzymes that stabilize their internal chemistry under acid stress. Even so, a significant fraction of live organisms in a supplement can die in transit.

Enteric-coated capsules are one practical solution. A study of L. acidophilus packaged in capsules coated with a pH-sensitive polymer found that the capsules remained intact in simulated stomach acid but dissolved in simulated intestinal fluid, preserving about 95% of viable cells through the coating process. Not all supplements use enteric coating, though, and the ones that do not are relying on sheer numbers — packing enough live organisms that enough survive the stomach to be useful. This is one reason colony counts on labels are in the billions.

Storage Matters More Than You Think

Once you bring a probiotic home, how you store it affects whether those billions of organisms are still alive when you take them. Lactobacillus and Bifidobacterium are vegetative cells, not spores, which makes them more fragile than spore-forming probiotics like Bacillus. A 12-month storage study comparing L. acidophilus cells to Bacillus spores in baked goods found that L. acidophilus fell below a meaningful therapeutic level after just two to four months, while the Bacillus spores remained stable throughout the year.

Temperature and oxygen exposure are the two biggest enemies. A study of a probiotic Lactiplantibacillus plantarum powder found that vacuum-sealed packaging stored at refrigerator temperature maintained the highest viability, while non-vacuum packaging at warm temperatures showed the steepest decline, though even under those worse conditions cells stayed above a functional threshold for about two weeks. If your supplement says “refrigerate after opening,” take that seriously. If it says “shelf stable,” it has likely been formulated with protective excipients or uses strains selected for room-temperature hardiness, but keeping it cool will still extend its useful life.

Safety for Most, Caution for Some

For healthy adults and children, Lactobacillus and Bifidobacterium supplements have an excellent safety track record. But “probiotic” does not automatically mean “harmless for everyone.” Case reports have documented rare but serious infections including bloodstream infections, heart valve infections, and liver abscesses caused by probiotic strains, almost always in people who were severely immunocompromised, critically ill, or had central venous catheters. If you have a weakened immune system or are managing a serious illness in a hospital setting, talk to your doctor before starting any probiotic.

Neurotransmitter Production

An active area of research involves the ability of both Lactobacillus and Bifidobacterium to produce neurotransmitters, the chemical signals your brain and nervous system use to communicate. Species from both genera have been identified as producers of GABA, dopamine, serotonin, and acetylcholine. The production of GABA, in particular, has attracted attention because of its role in calming nervous system activity. Metagenomic studies of the gut microbiome have confirmed that Lactobacillus and Bifidobacterium species contain the enzyme systems needed to produce GABA, and early evidence suggests that supplementation with these GABA-producing bacteria, sometimes called “psychobiotics,” may help improve neurotransmitter balance and reduce anxiety-related behaviors.

The honest assessment is that this research is still in its early stages. Most of the evidence for mood or cognitive effects comes from animal studies and small human trials, and the gap between “bacteria in a petri dish can make GABA” and “swallowing those bacteria changes your brain chemistry” is enormous. Still, the gut-brain axis is real, and these two genera sit right at the center of the conversation about how gut microbes might influence mental health.

Geographical Fingerprints in Bifidobacterium

An intriguing wrinkle in the science of these bacteria is that different human populations carry genetically distinct lineages. A genomic study of B. adolescentis, one of the most common Bifidobacterium species in the adult gut, identified seven distinct genetic clusters within the species, and those clusters partially tracked with the geographic origin of the human hosts the bacteria were isolated from. This suggests that Bifidobacterium strains have been co-evolving with human populations over long periods, adapting to the local diet and immune environment of their hosts. It is a reminder that “Bifidobacterium” is not a single thing but a deeply diverse group shaped by the same forces that shaped us.